Your browser doesn't support javascript.
loading
Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease - Data from the multicenter CEDATA-GPGE registry study.
Claßen, Merle; de Laffolie, Jan; Claßen, Martin; Schnell, Alexander; Sohrabi, Keywan; Hoerning, André.
Affiliation
  • Claßen M; Clinic for Children and Adolescent Medicine, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • de Laffolie J; Abteilung für Allgemeine Pädiatrie und Neonatologie, Justus Liebig University Gießen, Gießen, Germany.
  • Claßen M; Klinik für Kinder- und Jugendmedizin, Klinikum Bremen-Mitte, Bremen, Germany.
  • Schnell A; Clinic for Children and Adolescent Medicine, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Sohrabi K; Abteilung für Allgemeine Pädiatrie und Neonatologie, Justus Liebig University Gießen, Gießen, Germany.
  • Hoerning A; Clinic for Children and Adolescent Medicine, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Front Pediatr ; 10: 903677, 2022.
Article in En | MEDLINE | ID: mdl-36304532
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Pediatr Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Front Pediatr Year: 2022 Document type: Article Affiliation country: